Invasive fungal infections

Article Sidebar

PDF HTML
Published: 2022-09-19
DOI: https://doi.org/10.7196/AJTCCM.2022.v28i3.264

Main Article Content

S Kwarteng Owusu
Kwame Nkrumah University of Science and Technology, Kumasi, Ashanti Region, Ghana

Abstract

-

Downloads

Download data is not yet available.

Article Details

Issue

AJTCCM Vol. 28 No. 3

Section

Editorials
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited. 

Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository. 

How to Cite

1.
Kwarteng Owusu S. Invasive fungal infections. Afr J Thoracic Crit Care Med [Internet]. 2022 Sep. 19 [cited 2025 Oct. 2];28(3):100-1. Available from: https://samajournals.co.za/index.php/ajtccm/article/view/235

References

Spellberg B. Vaccines for invasive fungal infections. F1000 Med Rep 2011;3:13. https:// doi.org/10.3410/M3-13.

Kaushik N, Pujalte GG, Reese ST. Superficial fungal infections. Prim Care Clin Off Pract 2015;42:501-516.

Hobson RP. The global epidemiology of invasive Candida infections: Is the tide turning? J Hosp Infect 2003:55:159-168.

Ameen M. Epidemiology of superficial fungal infections. Clin Dermatol 2010;28(2):197-201. https://10.1016/j.clindermatol.2009.12.005.

Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: Human fungal infections. Sci Transl Med 2012;4(165):165rv13.

Hlophe ST, Jeena P, Mahabeer Y, Govender N, Masekela R, Ogunsakin RE. Invasive fungal infections in a paediatric intensive care unit in a lower- to middle-income country. Afr J Thoracic Crit Care Med 2022;28(3):x-x. https://doi.org/10.7196/ AJTCCM.2022.v28i3.xx

Filioti J, Spiroglou K, Roilides E. Invasive candidiasis in pediatric intensive care patients: Epidemiology, risk factors, management, and outcome. Intensive Care Med 2007;33: 1272-1283.

Zaoutis TE, Heydon K, Localio R, Walsh TJ, Feudtner C. Outcomes attributable to neonatal candidiasis. Clin Infect Dis 2007;44:1187-1193.

Kelly MS, Benjamin DK, Smith PB. The epidemiology and diagnosis of invasive candidiasis among premature infants. Clin Perinatol 2015;42(1):105-117. https://doi. org/ 10.1016/j.clp.2014.10.008

Park B, Wannemuehler K, Marston B. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009;23(4):525- 530. https://doi.org/10.1097/QAD.0b013e328322ffac

Mennink-Kersten MA, Verweji PE. Non-culture-based diagnostics for opportunistic fungi. Infect Dis Clin 2006;20(3):711-727.

Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: A 10-year review. Pediatr Radiol 2003;33:453-460.

Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndromes. Clin Infect Dis 2004;39(2):199-205. https://doi.org/10.1086/421944

Zaoutis TE, Jafri HS, Huang LM, et al. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics 2009;123(3):877-884.

Queiroz-Telles F, Berezin E, Leverger G, et al. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: Substudy of a randomized double-blind trial. Pediatr Infect Dis J 2008;27(9):820-826.

Nett J, Andes DR. Antifungal agents: Spectrum of activity, pharmacology, and clinical indications. Infect Dis Clin North Am 2016;30(1):51-83. https://doi.org/10.1016/j. idc.2015.10.012

Cadena J, Thompson GR, Patterson TF. Invasive aspergillosis: Current strategies for diagnosis and management. Infect Dis Clin North Am 2016;30(1):125-142. https:// doi.org/10.1016/j.idc.2015.10.015

Dornbusch HJ, Manzoni P, Rollides E, Walsh TJ, Groll AH. Invasive fungal infections in children. Pediatr Infect Dis J 2009;28(8):734-737.